Confidential mandate

Commodity Curve and Valuation Model Director

Planned Hiring / New

Commodity Curve and Valuation Model Director mandate in Paris, France

Confidential Commodity Curve and Valuation Model Director in Paris, France, reporting to the Chief Risk Officer. Consulting Quantitative Analysis appointment at Director level, a 8-month mandate horizon; four days a week.

The mandate

This bounded project will design and test a quantitative method for commodity curve construction and valuation control without revealing instrument, market or client specifics. The Director must create reproducible treatment of sparse observations, location and quality differentials, seasonality, optionality and illiquidity. The commission does not set commercial views, execute positions or issue an independent valuation opinion.

Deliverables comprise a data-source hierarchy, observability and fallback rules, curve methodology papers, parameter governance, model implementation specification, valuation-adjustment design, sensitivity and uncertainty framework, test catalogue, pilot results and owner guide. Each methodological choice must state its evidence, use boundary and behaviour when reliable observations disappear.

Five milestone dates apply: scope accepted by 13 November 2026; data and observability diagnostic by 8 January 2027; methodology and implementation specification by 5 March; pilot and challenger comparison by 16 April; internal reproduction and final acceptance by 28 May. The Chief Risk Officer accepts outputs after designated valuation and model-risk reviewers document their assessment.

Review packs must show how the curve behaves at observed knots, between them and beyond the final reliable point, including sensitivities to fallback selection.

Acceptance requires an internal team to rebuild selected curves from approved sources, respond correctly to seeded stale, contradictory and missing observations, reproduce valuation and sensitivity outputs within agreed tolerances and explain model limitation. Critical data-lineage or implementation defects must close before sign-off.

Management provides approved market sources, valuation populations, existing methods, transaction-independent reference facts and timely policy decisions. Consulting owns artifacts and testing; management owns commercial assumptions, prices, entries and representations. Trading strategy, price negotiation, platform implementation, independent validation and daily production are excluded.

What you will own

  • Define instrument-agnostic data hierarchies with observability, liquidity, staleness and fallback criteria.
  • Specify curve construction across interpolation, extrapolation, seasonality, basis, location and quality effects.
  • Quantify uncertainty and valuation adjustments where market evidence is sparse or conflicting.
  • Establish parameter, version and change controls with independent implementation checks.
  • Compare proposed methods against transparent challengers and explain divergence under stressed observations.
  • Pilot valuation and sensitivities, seed data failures and verify remediation through repeat testing.
  • Train internal quantitative owners to reconstruct curves and communicate limitations without consultant support.
  • Route trading, commercial, technology and recurring-production requests through formal change control.

Candidate qualifications

  • Demonstrate quantitative leadership in commodity curve construction under sparse or heterogeneous observations.
  • Describe a fallback method that produced misleading continuity and how you corrected it.
  • Show treatment of seasonality, basis or optionality without relying on unexamined historical fit.
  • Evidence a valuation uncertainty or adjustment method that remained explainable to senior governance.
  • Provide an internal reproduction test involving stale or contradictory market information.
  • Explain how you separated quantitative market evidence from commercial price views.
  • Show scope discipline when platform or daily-production work was requested.

Working terms and boundaries

  • Commercial consideration covers the eight-month commission, its four-day weekly cadence and five scheduled delivery gates.
  • Formal sign-off belongs to the Chief Risk Officer after internal challenge, successful reproduction and critical-defect closure.
  • Management owns market views, prices, transactions and representations; consulting owns the specified method artifacts.
  • Source and decision delays enter documented dependency governance before schedule revision.
  • Trading, negotiation, platform build, independent valuation or validation, and production operation are excluded.

Application

Applications for this mandate are received in one way only: through the India Board Terminal's application process. It is automated end to end. Your Executive Passport travels to the mandate holder in its confidential form, your answers to the three questions below are read before anything else in your file, and every stage that follows is recorded on your applications page.

There is no address to write to and no intermediary to call. The mandate holder reads what the Terminal delivers and nothing else, which is what keeps the process the same for every applicant and keeps your name out of it until you release it. Applications close on 8 October 2026. Mandate reference QNT-CON-2026-PAR-12.

More seats like this one

Every live mandate, by seat →

This mandate is confidential. The client is named only under a mutual NDA, and your own record is never listed, sold or shown to a company under your name until you release it for this specific mandate.